<DOC>
	<DOC>NCT02457585</DOC>
	<brief_summary>Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11</brief_summary>
	<brief_title>Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis</brief_title>
	<detailed_description>Clinical study of anti-tumor necrosis factor therapy in patients with Takayasu arteritis. This study is single arm (anti Tumor necrosis factor therapy only) clinical trial. Enrolled patients will be 11 patients with active takayasu's arteritis</detailed_description>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Arteritis</mesh_term>
	<mesh_term>Takayasu Arteritis</mesh_term>
	<mesh_term>Aortic Arch Syndromes</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>active takayasu's arteritis active Tuberculosis Liver function abnormality heart failure ( New York Heart Association III IV) patients were not consented</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>